ViXionïŒãŽã£ã¯ã·ãªã³ïŒãå瀟ã®ãªãŒããã©ãŒã«ã¹ã¢ã€ãŠã§ã¢ãViXionãã·ãªãŒãºã®èŠéé¢ç©ãçŽ2.4åã«æ¡å€§ããæ°ã¢ãã«ãViXion2ãã2026幎4æ17æ¥ã«çºå£²ããã
3æ17æ¥ããå šåœã®åæ±åºãšå ¬åŒãªã³ã©ã€ã³ã¹ãã¢ã«ãŠå è¡äºçŽåä»ãéå§ããããåžæå°å£²äŸ¡æ Œã¯11äžåã ã
-

ææ°ã®ãªãŒããã©ãŒã«ã¹ã¢ã€ãŠã§ã¢ãViXion2ãã察象ç©ã«åãããŠç¬æã«ãã³ãã調ç¯ãã
èŠéã®åºãã2.4åã«é²åãããªãŒããã©ãŒã«ã¹ã¢ã€ãŠã§ã¢
ViXionã¯èŠèŠã«äžèªç±ãæããŠãã人åãã®é»åããã€ã¹ã®éçºã販売ããœãªã¥ãŒã·ã§ã³ãæäŸããŠããã2021幎ã«HOYAããææèŠæ¯æŽã¡ã¬ãã®äºæ¥ãè²åããŠå¶æ¥ãéå§ããäŒæ¥ã ã
å瀟ã«ããã°2000å¹Žåœæ14å人ã ã£ãäžçã®èçŒäººå£ã¯2030幎ã«21å人ã«éãïŒåºæïŒæ¥æ¬èèŠåŠäŒïŒãåæ§ã«14å人ã ã£ãè¿èŠäººå£ã¯2050幎ã«ã¯50å人ã«éãããšããïŒåºæïŒåœé£ãWorld Population Prospects The 2019 RevisionãïŒHolden, et al, 2016 OphthalmologyïŒããã³ã調ç¯äžå šãšãã瀟äŒèª²é¡ã¯äžçã®æ©ã¿ã§ãããã
-

ViXionæ ªåŒäŒç€Ÿä»£è¡šåç· åœ¹ã®åéšèª äžéæ°ïŒå³ïŒãšViXion01ã®çºæè ã§ãããå瀟åç· åœ¹æé«ã€ãããŒã·ã§ã³è²¬ä»»è ïŒCINOïŒã®å æµ·ä¿æŽæ°
ãªãŒããã©ãŒã«ã¹ã¢ã€ãŠã§ã¢ãšããã®ã¯èãæ £ããªãèšèã ããæ©ã話ãèªåã§ãã³ããåãããçŒé¡ã ããã©ãŒã«ã¹ãåãããçèãèªåã§äœ¿ãå¿ èŠããªãã
ãããŠæ°è£œåã§ã¯ãåã¢ãã«æ¯2.4åã®é¢ç©ã確ä¿ãå§åçã«åºãèŠçãåŸãããšãã§ããããã«ãªã£ãã
å·Šå³ã®9ããªåŸã¬ã³ãºãå·Šå³ã®ç®ã§åå¥ã«ã®ããã5cmããç¡éé ãŸã§ã®çŠç¹è·é¢ããªãŒããã©ãŒã«ã¹ã§åçŠãããããã£ãŠã¿ãã°ããªãŒããã©ãŒã«ã¹ã«ã¡ã©ã®å åŠãã¡ã€ã³ããŒãäž¡ç®ã®åã«ããã€ã¡ãŒãžã ã
ããã«ã¢ã¿ããã¡ã³ãçãªäœçœ®ã¥ãã§ã¢ãŠã¿ãŒãã¬ãŒã ã忢±ãããæ¬äœã«è£ çããŠãµã³ã°ã©ã¹é¢šã«ããããä¹±èŠç¯æ£ãªã©ã®ããã«åºŠä»ãã®ã¬ã³ãºãéãåããããããããšãã§ããã
ãã¡ããé è¿äž¡çšã¡ã¬ããã»ããããŠããããšãã§ããããããã«ã€ããŠã¯ãããã¯ã«ã¡ã©ããªãŒããŒã¡ã€ãçŒé¡å°éåºã®JUNé座ãªã©ã§åãä»ããŠããããã
å¢ç®ã®ãªãé è¿äž¡çšçŒé¡ãšããŠããªã©ãã¯ã¹ã1959幎ã«ç»å ŽãããŸã§ã®ããã€ãŠã®é è¿äž¡çšçŒé¡ã¯ãã¬ã³ãºã®ç¹å®éšåã«å°çªãã€ãããããªäºéçŠç¹ã¬ã³ãºã ã£ãããã ããçŸæç¹ã§ã®ViXionã¯ããã«è¿ããç»æçãªãœãªã¥ãŒã·ã§ã³ã ã
ã©ããã£ãŠç¬æã«ãã³ããåãããŠããïŒ
ä»çµã¿ãšããŠã¯æ¶²äœã¬ã³ãºãšè·é¢ã»ã³ãµãŒãé£åãããã³ãåããããªãŒãã§è¡ããå·Šå³ã®ã¬ã³ãºã®çãäžãã¡ããã©éŒ»ã®äžã®ããªããžéšåã«è·é¢ã»ã³ãµãŒãä»èŸŒãŸããŠããŠãèŠãããšãã察象ãšã®è·é¢ã枬å®ããã®è·é¢ã«å¿ããŠã¬ã³ãºåœ¢ç¶ãç¬æã«å€åãããŠèªåã§ãã³ããåãããã
調ç¯ã¯çŽ0.1ç§ããŸãã«ã«ã¡ã©ã®ãªãŒããã©ãŒã«ã¹ãã®ãã®ã ããã³ãäœçœ®ã¯ãã³ãã«ã®æ ¹æ¬ã®ã¿ããæäœã§ä»»æã®è·é¢ã«åºå®ããããšãã§ããã
æ¶²äœã¬ã³ãºã¯ãæ°Žã«æ²¹ãå ãããã®ã§ãæ°Žéšåã«é»å§ãå ãããšãæ²¹éšåã®åœ¢ç¶ãå€åãããé»å§ãå¯å€ããŠåžãšå¹ã®ç¶æ ã調ç¯ããããšã§ãã³ãäœçœ®ãå€ããããããé»å§ã¯æ°åãã«ãã ããã ã黿µã¯ã»ãã®ããããªã®ã§æé»ãªã©ã®å¿é ã¯ãªããšããã
å èµã®ãªããŠã ããªããŒé»æ± ã¯æ¬äœã®USB-CããŒãããå é»ãããçŽ3æéã§æºå é»ã«ãªããçŽ15æéã®äœ¿çšãå¯èœã ãå¯ãŠãããšãã«å é»ããã°ãèµ·ããŠããå¯ããŸã§ã®éã¯ãã£ãšã€ããŠããããæ³å®ã ã
ä»åã¯9ããªåŸãšãªã£ããããã£ãšå£åŸã倧ãããªãã°ãã£ãšèŠããããªãã®ã¯ããã£ãŠãããã ããã¬ã³ãºã¯å¿ ãç³ã«å¯ŸããŠç«ãŠãç¶æ ã§è£ çãããããéåã«ãã£ãŠæ¶²äœãäžã«åããŠæªãã§ããŸããã¬ã³ãºåŸã倧ãããªããšãéåã®åœ±é¿ã倧ãããªãã軜éåãå®å®åãé£ãããªãã®ã ããã ã
ããªã¹ã³ãŒããªã©ã®ããªãºã å©çšã§å 軞ã調æŽããã°å®çŸã§ããããªãã®ã ããããã¯åå±ãåžããªãããã ã
1æ¬ã§å šè·é¢ãèŠããçæ³ã®ã¡ã¬ããã«æåŸ å€§
å人çã«ã¯èªå® ã®ãã¹ã¯ãããããœã³ã³ã倧ç»é¢ãã£ã¹ãã¬ã€ã§äœ¿ãããã«1ã¡ãŒãã«ã¡ã¬ããåºå ã§ããŒãããœã³ã³ãæäœããããã«60ã»ã³ãã¡ã¬ããææããŠãããããããã®è·é¢ã«æé©åããã¡ã¬ãã ã
ããã ãã§ã¯æ¥åžžç掻ã«ã¯è¶³ãããèªæžãªã©å°å·ç©ã®é²èЧãã¹ããæäœããããŠé ããèŠãããã®é è¿äž¡çšçŒé¡ãçšæããŠãããããããšã«å¿ããŠã¡ã¬ãããšã£ããã²ã£ããããããšã«ãªãããã²ãšã€ã®ã¡ã¬ãã§å šè·é¢ããªãŒããã©ãŒã«ã¹ã§ããã°çæ³çã ã
å åŠãã¡ã€ã³ããŒã§ã¯ãªãEVFçžåœã®XRã¡ã¬ããªãã¯ãªã¢ã§ããããªèª²é¡ã ãããããŸã§ããªã¢ã«ãªå ããšããããã
ä»åã®æ°è£œåã§ViXionã¯å 代ã«å¯ŸããŠé£èºçã«èŠéãåºãããããã¯çŽ æŽãããããšãªã®ã ããã©ãããŠãé¡åŸ®é¡ãèŠãã€ã¡ãŒãžããã£ãŠãåºã ãšããèŠéã確ä¿ã§ãããšã¯èšãé£ãã
ã¬ã³ãºã®äžäžã§ãªã ããã«çŠç¹è·é¢ãå€ãã环é²å±æã¬ã³ãºã«ãããå¢ç®ã®ãªãé è¿äž¡çšçŒé¡ãã§ãããã£ãšããããæããã»ã©ã«ã人éã®ç³ã¯ææã ãèŽ æ²¢ã§ã¯ããããæåŸ ããã£ãŠãããªãé²åãæã¿ããã